Unveiling the Potential: USA Animal Model Market Outlook by 2023 to 2033

 The USA animal model market has reached a remarkable valuation of approximately USD 976.1 million in 2023, signaling a significant milestone in biomedical research and development. According to a comprehensive study by Future Market Insights, the demand for animal models within the USA is projected to witness a robust growth trajectory, with an anticipated Compound Annual Growth Rate (CAGR) of 4.3% from 2023 to 2033.

The study forecasts a surge in demand for animal models, with an estimated value reaching USD 1,487.9 million by 2033. This growth underscores the indispensable role of animal models in various research domains, contributing significantly to scientific advancements and innovative breakthroughs.

Mice have emerged as the dominant species within the USA market, holding a substantial share of over 61.03% in 2022. Their versatility and genetic proximity to humans have rendered them invaluable assets in preclinical trials and biomedical studies, leading to their widespread utilization across research laboratories.

Get Your Report Sample: https://www.futuremarketinsights.com/reports/sample/rep-gb-14527

The projected growth signifies a burgeoning demand for sophisticated research methodologies and the continual pursuit of advancements in the biomedical sector. Leveraging animal models remains indispensable for developing novel therapies, understanding disease mechanisms, and facilitating the progress of pharmaceutical and biotechnological innovations.

"This substantial growth in the USA animal model market underscores the indispensable role of these models in driving scientific progress," stated a representative from Future Market Insights. "The anticipated rise reflects the ongoing commitment of the biomedical community toward fostering innovative research methodologies and advancing medical breakthroughs."

As the USA animal model market expands, stakeholders within the biomedical and pharmaceutical industries are poised to embrace new opportunities, fostering collaborations, and investing in cutting-edge technologies to further enhance research outcomes.

Key Takeaways from the USA Animal Model Market Study Report:

  • Back in the year 2017, the demand for animal models in the United States, in terms of value, was nearly 818.7 million.
  • Over the next ten years, the animal model market in the United States is projected to witness an absolute growth of USD 540.6 million.
  • Based on different species types, mice are the most preferred models and acquire a market share of 61.03% in the United States.
  • Among the different end-user verticals, most of the demand for animal-based models comes from academic and research institutes. This segment generated a revenue of around USD 352.5 million in 2022, which was figured out to be 37.21% of the market.

Competitive Landscape for the USA Animal Model Market Players:

Key firms in the market are using strategic formulations including forward integration, global expansion, and research alliances to maximize their revenue share and foster business growth. As there are many established participants in the supply of animal models, the overall USA market is fairly distributed and fragmented. However, the market is somewhat consolidated by large investments made by the DARPA and National Institutes of Health in the last few years.

Recent Developments by the Animal Model Industries based in the USA:

  • The Jackson Laboratory Inc. reported in February 2020 that a specific hACE2 genetically altered mouse model was available to aid COVID-19 research. This change presented fresh chances to create cutting-edge transgenic mice study models for the best results in clinical studies.
  • Charles River Laboratories Inc. and genOway, which is a biotechnology research company that creates transgenic research models, announced their alliance in May 2018. 2000 Ready-to-Use Knockout Mouse Models were to be made available through this agreement for in vivo research projects. The firm was able to strengthen its market position and obtain an edge over others after this strategic relationship.

Key Companies Profiled:

  • Charles River Laboratories
  • The Jackson Laboratory
  • Taconic Biosciences, Inc.
  • Genoway
  • Envigo (Inotiv, Inc.)
  • Marshall BioResources
  • Janvier Labs
  • Applied stem cells
  • Biocytogen
  • Transposagen Biopharmaceuticals, Inc. (Hera Bio Labs)
  • Cyagen
  • Ingenious targeting labs
  • Crown Bioscience Inc. (JSR Corporation).
  • Harbour Biomed
  • Sinclair BioResources
  • Alpha Genesis Inc.
  • Creative Animodel
  • DaVinci Biomedical Research Products, Inc

Key Segments Covered by USA Animal Model Industry Survey Report:

By Species:

  • Mice
  • Rats
  • Fish
  • Birds
  • Cattles
  • Pigs
  • Amphibians
  • Guinea Pigs
  • Dogs
  • Cats
  • Rabbits
  • Monkeys
  • Sheep
  • Hamsters
  • Other Animals

By Technology:

  • Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)
  • Microinjection
  • Nuclear Transfer
  • Other Technologies

By Application:

  • Research & Development
    • Infectious Disease
    • Immunological Diseases
    • Cancer
    • Cardiovascular Diseases
    • Diabetes
    • Genetic Diseases
    • Neurological Diseases
    • Obesity
    • NAFLD or NASH
    • Renal disease
    • Diabetic eye disease
    • Fibrosis
    • Micro-biome
    • Other Research and Developments
  • Production and Quality Control
  • Academics
  • Preclinical Applications
    • Infectious Disease
    • Immunological Diseases
    • Cancer
    • Cardiovascular Diseases
    • Diabetes
    • Genetic Diseases
    • Neurological Diseases
    • Obesity
    • NAFLD/NASH
    • Renal disease
    • Diabetic eye disease
    • Fibrosis
    • Micro-biome
    • Other Preclinical Applications
  • Other Applications

By Use:

  • Human
  • Veterinary

By End-user Verticals:

  • Companies
    • Pharmaceutical
    • Biotechnology
    • Cosmetics
    • Other Companies
  • Organizations
    • Government
    • Non-government
  • Academic and Research Institutes
  • Contract Research Organizations (CRO)

Comments

Post a Comment

Popular posts from this blog

Beyond COVID-19: A Look at Vaccines Market Post-Pandemic From 2023 to 2033

Image
 In recent years, the Vaccines Market has undergone a dramatic transition brought on by ground-breaking scientific discoveries and the pressing need for universal immunisation. The COVID-19 pandemic acted as a stimulus for a surge in vaccine demand that has prompted academics and pharmaceutical corporations to develop at a previously unheard-of rate. This blog examines the changing market environment for vaccines, highlighting significant trends, difficulties, and opportunities. Technology advancements like mRNA and vector-based platforms have completely changed how vaccines are developed. These innovative techniques have proven to be remarkably effective against contagious illnesses like COVID-19, opening the door for the development of new vaccines. In response to the pandemic, mRNA vaccines were developed and distributed quickly, showcasing the promise of these ground-breaking technology. Supercharge Your Knowledge: Dive into the Booming Vaccines market with Our Sample Report @ ht
Read more

Key Players Shaping the 3D Cell Culture Market: By 2022 to 2031

Image
  The global 3D cell culture market is anticipated to account for a growth rate of around 9.8% over the forecast period from 2022 to 2031. The global market is expected to account for around US$ 1.15 Billion in 2022 and attain a valuation of US$ 2.67 Billion by 2031. According to the analysis done by Future Market Insights, the global 3D cell culture market accounted for a CAGR of 4.8% in 2021. During the historical period of 2016 to 2021, the 3D cell culture market expanded at a CAGR of 7.1%. According to the studies conducted by Future Market Insights, the comparative analysis along with the market growth rate of the global 3D cell culture market is expected to show a negative BPS growth in the H1-2022 outlook as compared to H1-2022 projected period by 10 BPS, However, a positive BPS growth is expected in H1-2022 over H1- 2021 duration with 02 Basis Point Share (BPS). The global 3D cell culture market observes a drop in the BPS values owned to its disadvantage as compared to surface
Read more

Technological Advancements Fueling the Physiotherapy Equipment Market By 2023 to 2033

 The physical well-being and quality of life of people who are recuperating from injuries or who have chronic diseases are greatly enhanced by physical therapy. The Physiotherapy Equipment Market has experienced growth in tandem with the increase in demand for physiotherapy services. Due in large part to technological innovation, the prevalence of neurological and musculoskeletal illnesses is rising, and this sector of the economy is expanding quickly. The market for physiotherapy equipment has a large selection of gadgets and instruments made to help with the healing process. The industry has made considerable strides to meet a variety of treatment demands, from heat and cold therapy devices to electrotherapy machines and therapeutic exercise equipment. These contemporary resources help physiotherapists deliver more focused care, increase patient results, and enrich the therapeutic process as a whole. Grab Your Exclusive Report: Unveiling the Spectacular Growth of the Physiotherapy E
Read more